on DIAGNOSTIC MEDICAL (EPA:ALDMS)
DMS Group obtains FDA approval for the !M1
DMS Group has achieved a strategic milestone in the United States with FDA approval of its !M1 mobile radiology system. This success strengthens its partnership with JPI Healthcare Solutions for the commercialization of !M1 in the US market. The official launch of the solution, under the name TrueMobile Apex, will take place at RSNA 2025 in Chicago.
The US market, considered dynamic for medical imaging solutions, is a priority for DMS Group. The company has already recorded significant revenue growth of 93% in North America for the first nine months of 2025, reaching €5.1 million. The system also integrates Trixell's advanced Pixum EZ-C X detector.
R. P.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all DIAGNOSTIC MEDICAL news